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A synthetic peptide (rab3AL) correspondmg to the erector domam of rab3, a small GTP-bmdmg protein, stimulated basal and potentiated Ca”- 
as well as GTPyS-evoked insuhn secretion about Z-fold from streptolysin-0 permeablhzed HIT cells. This effect was specific, since the analogous 
peptides of ras or rabl did not affect the exocytotic event. The more than additlre effect of rab3AL on Ca” or GTPyS stimulation indicates a 
distinct mode of action of the peptide. The partial loss of cytosohc proteins from permeabilized ceils was accompanied by a faster run-doun of 
the secretory response to Ca” than the one to GTP@. The persistent effect of rab3AL under these conditions points to a inembrane locahzation 
of Its target. These results suggest hat rab3 and its effector are involved m the regulation of insulin secretion. 
GTP-binding protem; Insulin secretion: Calcrum; Rab protein; Exocytosis 
1. INTRODUCTION 
The ras and ras-related proteins belong to a large 
family of small molecular weight GTP-binding proteins 
(SMG), which regulate many functions such as cell 
growth and intracellular vesicle transport [i-5]. The 
activity of these proteins depends on whether they bind 
GDP or GTP. These SMGs have an intrinsic, albeit 
weak, GTPase activity [l-5]. 
The interconversion of the inactive, GDP-bound 
form and the active form of the SMGs is regulated by 
several proteins [l-3]. One of these, GDP-dissociation 
inhibitor (GDI), is only present in the cytosol and com- 
bines with the GDP-bound form of the SMG, thereby 
inhibiting its activation. Another regulatory protein, 
GDP-dissociation stimulator (CDS), activates SMGs 
by accelerating the release of GDP and the binding of 
GTP. This will result in a conformational change in the 
SMG and cause the interaction, via the effector domain, 
with its target. The GTP-bound form of SMGs is inac- 
tivated by GTPase-activating protein (GAP), promot- 
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ing the hydrolysis of GTP to GDP, The CD1 removes 
the GDP form of the SMG from membranes. 
All ras-related SMGs contain five conserved regions 
which are important for the binding of guanine nucleo- 
tides and the hydrolysis of GTP, as well as for the 
interaction with GDS and GAP [l--3]. Most SMGs are 
post-translationally modified by isoprenylation at the 
C-terminus 161. This lipidation is essential for their fimc- 
tion, since it ascertains their correct targeting to mem- 
branes as well as the interaction with GDI [3,6]. The 
GAP-binding part is also denoted effector domain, 
since mutations in this region result in loss of function 
[7]. This region is conserved within a given subfamily 
but diverges substantially between different SMG sub- 
families [l--3]. Therefore, one of the strategies for exam- 
ining SMG function is the use of their effector domain 
peptides to expfore their potentiai effects. 
The rab proteins are a subfamily of SMGs, contain- 
ing at least 15 members [4,5,8], all of which have been 
implicated in one or more of the vesicular transport 
steps from endopiasmic reticulum to Golgi complex, 
between Golgi cisternae, and in endocytosis and exocy- 
tosis [4,5]. One of them. rab3A, is particularly interest- 
ing since this protein is present only in brain and secre- 
tory cells [3-51, including insulin-secreting cells [9]. Sev- 
eral regulatory proteins for the rab3 subfamily have 
been discovered, including CD1 [lo], GAP [ 11,121 and 
GDS 1121. The potential function of rab3A is suggested 
by its predominant location on the membrane of secre- 
tory granules and by its similarity with the sec4 protein 
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Fig. 1. Doseeresponse of rab3AL peptide on msulm secretton from 
SL-0 permeabihzed HIT cells. Cells were permeabtlized by incubation 
with 1.5 U/ml SL-0 for 5 min. Thereafter the medium was changed 
to one containing different concentrations of rab3AL peptide. After 
5 min. the sttmulatmg solution was added and the cells were incubated 
for another 5 min. Insulm in supernatants and attached cells was 
measured for the assessment of secretion and cellular content, respec- 
tively. Values are from one representative experiment in quadrupli- 
cate. Similar results were obtained in two other Independent expert- 
ments. 
which controls secretion in yeast [13]. It has thus been 
reported that the rab3A protein may participate in neu- 
rotransmitter release [ 14,151. A synthetic peptide corre- 
sponding to the putative effector domain of this SMG, 
except for the exchange of two amino acids (denoted 
rab3AL). was shown to affect intracellular vesicle trans- 
port [16]. 
Previous work has demonstrated that poorly hydro- 
lizable GTP analogs can trigger exocytosis via a path- 
way independent of phospholipase C and protein kinase 
C in insulin-secreting cells [17]. The underlying mecha- 
nism is still poorly understood. The involvement of a 
G-protein directly controlling exocytosis and named G, 
has been postulated [18]. The identity of this protein 
remains, however, elusive. In the present study, the pos- 
sible role of the small GTP-binding protein rab3 in the 
regulation of insulin secretion is examined. For this 
purpose we used the synthetic peptide rab3AL to inves- 
tigate its action on exocytosis in permeabilized HIT-T1 5 
cells. 
2. MATERIALS AND METHODS 
Peptides corresponding to the effector domain of rab3, ras and rabl 
were synthesized as prevtously described [16]. GTPyS and GDP/JS 
were purchased from Boehrmger Mannheim. Mannhetm. Germany 
and streptolysin-0 from Wellcome Diagnostics. Dartford. UK. 
The insulin-secreting cell line. HIT-T] 5, was ortginally provided by 
Dr. A.E. Boyd III (Tufts University. Boston. MA. USA). The cells 
(passages 70-79) were cultured in RPM1 1640 medium supplemented 
with 100 U/ml pemcillm, 100 &ml streptomycin and 10% fetal calf 
serum. Cells were seeded on mtcrotiter (0.28 cm’ x 96 wells) or mul- 
tiwell (I .77 cm’ x 24 wells) plates at a density of 3 x 10’ cells per cm’ 
and cultured for two days. 
For the measurement of msulm secretion from permeabilized cells 
[19.30]. the cells seeded m culture plates were washed twice with 
Ca”-free Krebs-Ringer bicarbonate-HEPES buffer and once wtth 
potassium glutamate buffer [21] at room temperature. Thereafter the 
cells were rendered permeable m the potasstum glutamate buffer con- 
taming l-l.5 Ltiml of streptolysm-0 (SL-0) for 5-8 mm at 37°C. after 
which the permeabthzmg solutton was removed. Cells were then prein- 
cubated m the potassium glutamate buffer with different concentra- 
tions of the synthettc pepttdes for 558 min and incubated for another 
558 mm with different concentrattons of Ca” and GTPyS m the 
contmuous presence or absence of the pepttdes. The supernatants were 
removed. centrifuged at 4°C and kept at -70°C until insulm assay 
The attached cells were extracted wtth acid/ethanol for insulin content 
determination [20]. Insulm was measured by radtoimmunoassay usmg 
rat insulin as standard. Cell permeability was examined by the trypan 
blue exclusion test. After SL-0 treatment. more than 95% of the cells 
were permeable to the dye. 
For detection of SMGs, the cells were homogenized and the SMGs 
were resolved by PAGE and blotted on mtrocellulose membranes. and 
revealed by the [Z’P]GTP-overlay technique exactly as prevtously de- 
scribed m detail [9,X] Protein was determined wtth the method of 
Bradford using bovine serum albumm as standard [Xl. 
The results are expressed as mean i- S.E.M. and analysed by two- 
tat1 unpaired Student’s t-test. 
3. RESULTS 
The doseeresponse effect of rab3AL on insulin secre- 
tion from SL-0 permeabilized HIT cells is shown in Fig. 
1. This peptide stimulated insulin secretion at basal (0.1 
PM) Ca” and clearly potentiated the secretory re- 
sponses both to 100 PM GTPyS, a poorly hydrolizable 
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Fig. 2. Effect of rab3AL pepttde on Ca‘+- and GTPyS-induced msulm 
secretion from SL-0 permeabilized HIT cells. Values are 
mean f S E.M. of four experiments. For experimental detail, see leg- 
end to Fig. 1. 
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Fig 3. Comparison of rab3AL and ras effector-domain peptides on 
insulin secretion from SL-0 permeabilized HIT cells. Values are 
mean f SE M of three replicates. For experimental detail. see legend 
to Fig. 1. *P < 0.01 compared to control. 
GTP analog, and to 10 PM Ca’+ in a dose-dependent 
manner. The maximal effect, more than 2-fold, was seen 
at 50 ,uM. The EC,, of the peptide on the secretion 
induced by GTPyS and 10 ,uM Ca” was between 10 and 
1.5 PM. The effects of rab3AL on different concentra- 
tions of Ca” and GTPyS-stimulated insulin secretion 
was further examined. Ca” dose-dependently stimu- 
lated insulin release from permeabilized HIT cells with 
an EC,, of about 4 ,uM. The peptide rab3AL (50 ,uM) 
potentiated the Ca” effect 2-fold at all Ca’+ concentra- 
tions from 10 nM to 100 ,uM (Fig. 2a). 50 PM rab3AL 
also potentiated the action of different concentrations 
of GTPyS on insulin release (Fig. 2b). GTPyS itself 
elicited secretion of the hormone in a dose-dependent 
manner with an EC,, of about 10 ,uM. At the higher 
GTPyS concentrations, the secretion was increased 
more than ‘-fold by the peptide. 
To test for the specificity of rab3AL. we also exam- 
ined two other synthetic peptides corresponding respec- 
tively to the effector domain of ras and rabl (for details 
including amino acid sequences. see [ 161). As shown in 
Fig. 3, the same concentration (50 ,DM) of ras effector- 
domain peptide did not significantly affect the insulin 
release either at basal or under the stimulation of 
GTPyS and high Ca’+. Similar negative results were 
obtained with 50 ,uM rabl effector-domain peptide (not 
shown). Furthermore, rab3AL had no effect on insulin 
release from intact cells incubated in KrebssRinger bi- 
carbonate-HEPES buffer (not shown). 
The site of action of rab3AL was investigated by 
stimulating insulin secretion at various times after the 
permeabilization of the cells. The holes in the plasma 
membrane in SL-0 permeabilized cells are large enough 
to allow cytosolic proteins to leak out [19]. The relative 
importance of cytosolic and membrane-associated pro- 
teins in the regulation of secretion could thus be evalu- 
ated. 
The secretory response to Ca’+ stimulation displayed 
a quick run-down after SL-0 permeabilization, while 
100 
1 
10 
0 
the run-down rate under either resting or GTPyS stim- 
ulation conditions was much slower (Fig. 4A). At 8 and 
16 min after permeabilization, the Ca7+ (10 ,DM) effect 
was decreased respectively by 45% and 80% but the 
GTPyS action was only slightly affected, indicating that 
Ca’+ action is more dependent on cytosolic factors. The 
peptide rab3AL (50 PM) did not cause any substantial 
insulin release during the first 8 min (Fig. 4B, compared 
to the control secretory rate in Fig. 4A), possibly due 
to the incomplete penetration of the peptide and the 
retained endogenous rab3 protein during this simulta- 
neous permeabilization and stimulation period. How- 
ever, GTPyS and Ca’+ induced insulin secretion was 
still potentiated to the same extent, 2-fold. by this pep- 
tide under the run-down conditions at 8 min and 16 min 
after permeabilization, although the maximal response 
to Ca7+ stimulation was not restored (Fig. 4B). These 
results suggest that the target of rab3AL is associated 
with the membranes and its mode of action is mainly 
one of potentiation. 
The profiles of protein and SMG distribution be- 
tween cytosol and membranes after SL-0 permeabiliza- 
tion were also examined. It was found that about 30% 
of the cytosolic proteins had leaked out while there was 
no change in the protein content in the membranes 
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Fig. 4. Effect of rab3AL peptide on msulin secretion at various ttmes 
after permeabdization of HIT cells. Cells were rendered permeable 
wtth 1 U/ml SL-0 for 8 min. Open bars: stimuh were added together 
with SL-0 and supernatants were removed for msulin measurement 
after 8 min. Hatched bars: after 8 min of SL-0 permeabihzdtion. the 
medrum was exchanged for one contaming stimuli and the ceils were 
incubated for another 8 min. Closed bars: after 8 mm of SL-0 perme- 
abrhzation. the cells were Incubated with fresh potassium glutamate 
buffer for 8 min. Thereafter, the medmm was replaced by stimulating 
buffer and cells were incubated for another 8 min. (A) Control incuba- 
tions in the absence of rab3AL peptide. (9) 50 PM rab3AL was 
included during the 8 min strmulation period. Values are 
mean f S.E.M. of four observatrons of one representatrve experiment. 
Srmtlar results were obtamed in two other independent experiments. 
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measured after 24 min permeabilization. These values 
were (mean + S.E.M. pug/well; n = 3): the cytosol pro- 
tein contents were 704 + 18 and 483 & 28 in intact and 
24 min permeabilized cells while the protein contents in 
the membrane fraction were 400 & 4 and 397 + 18 in the 
intact and permeabilized cells, respectively. Using the 
GTP-overlay technique, the SMGs migrating in the 
range of 21-27 kDa could be detected (Fig. 5), confirm- 
ing our previous work [9,22]. These SMGs were differ- 
ently distributed between cytosol and membranes. 24 
min after SL-0 pet-meabilization, there was also about 
a 30% loss of these SMGs in the cytosol but no decrease 
was detected in the pool associated with the membranes. 
The inclusion of GTPyS ( 100 PM) during the last 8 min 
incubation period did not alter the distribution profiles 
of either total protein or SMGs. There was no detecta- 
ble preferential reduction of a specified SMG, or group 
of SMGs, either in the cytosol or membranes. 
4. DISCUSSION 
Here we report that a synthetic peptide correspond- 
ing to the putative effector domain of rab3 affects the 
exocytosis of insulin-containing granules from a perme- 
abilized p-cell line. The peptide has a weak stimulating 
effect on insulin release at nonstimulatory concentra- 
tions of Ca’+ (10-100 nM). The main action observed 
is, however, the potentiation of Ca”- and GTPyS- 
evoked insulin secretion. Although the net amount of 
increased insulin release by rab3AL is different under 
the various conditions, the maximal augmentation was 
Cytosol Membranes ,7-p-. -p-p, 
25 kDa - 
23 kDa - 
20 kDa - 
ABCDEF 
Fig. 5. Subcellular dtstribution of small G-proteins at various times 
after permeabilization of HIT cells. The cells were washed twice and 
either directly homogenized (A.D) or treated with 1 U/ml SL-0 for 8 
min (B.C,E.F) Before homogenizatron, the permeabilized cells were 
incubated for 24 min at 100 nM free Ca”, with (C.F) or without (B.E) 
100 PM GTPyS Included during the last 8 mm incubatton. The cy- 
tosohc and crude membrane fractions were then prepared as prevt- 
ously described [9,22]. The SMGs present m the two fractions were 
revealed using the GTP-overlay technique [9.22]. Two bands detected 
on the films were quantified by densitometric scanning. The values 
obtained for the 23 kDa and 25 kDa bands were respectively (arbttrary 
units, mean of two determinations): lane A. 1,680 and 4,829; lane B, 
1.125 and 3,154; lane C, 1.261 and 3,277, lane D, 2,713 and 4.964, lane 
E, 2.300 and 4,981; and lane F. 2,522 and 5.284 
always a doubling of the secretion obtained in the ab- 
sence of the peptide. This effect is also more than addi- 
tive. taking the sum of the peptide plus Ca’+ or GTPyS, 
indicating a distinct mode of action of the rab3AL pep- 
tide. It has been reported that the same peptide stimu- 
lates exocytosis of secretory granules in permeabilized 
pancreatic acinar cells and chromaffin cells as well as in 
patch-clamped mast cells [24-261. In those studies, 
rab3AL only enhanced the secretion stimulated with 
Ca2+ and GTPyS in chromaffin cells, while in acinar 
cells the peptide increased the release under non- or 
substimulatory conditions. The native effector domain 
peptide of rab3 also affected exocytosis albeit with less 
efficacy [24,26]. The action of rab3AL on insulin release 
is specific, since two other peptides corresponding to the 
effector domain of ras and rabl did not stimulate the 
secretion and the peptide had no effect on intact cells, 
confirming the observations on the specificity of 
rab3AL in other studies [24-261. 
The ras protein exerts its function through the inter- 
action between its effector domain and its targets. The 
candidates for this role include GAP and other proteins 
[2,3]. It is postulated, assuming the same mechanism of 
action as for the ras protein. that the effector domain 
peptide rab3AL mimics native rab3 proteins and inter- 
acts with GAP or other target proteins. rab3A is mainly 
present in brain synaptic vesicles and neurosecretory 
cells [4.5]. Stimulation of neurotransmitter release was 
found to be accompanied by the dissociation of rab3A 
from the synaptic vesicles [14,15]. In HIT-T15 cells, 
rab3A is not detectable and only rab3B and rab3C are 
present ([27], and R. Regazzi, unpublished observa- 
tions). However, since the four subtypes (A, B, C and 
D) of rab3 proteins share an identical sequence in the 
effector domain [8.38,29]. rab3AL could mimic func- 
tions exerted by all these SMGs. 
Under normal conditions, most of the native rab3 
may be present in a GDP-bound form due to the activity 
of GAP. When rab3AL is added, it would bind to the 
rab3-specific GAP and the negative influence of the 
GAP on rab3 would be relieved. The endogenous rab3 
could now be activated by GTP for a longer time period 
and exert a stronger effect on exocytosis. In contrast, 
GTPyS (poorly hydrolizable) alone only caused a small 
increase in secretion and did not enhance the Ca’+- 
induced maximal insulin secretion ([21]. and unpub- 
lished observations). In view of the potentiation of this 
maximal insulin secretion by rab3AL. it appears that 
the G-protein mediating the action of GTPyS is not the 
endogenous rab3 protein. Thus, GAP may neither rep- 
resent a rate-limiting step nor be the main target of 
rab3AL in this case. It is more likely that the peptide 
acts on another rab3 target which regulates exocytosis. 
The fusion between isolated granules and plasma mem- 
brane from pancreatic acinar cells has also been re- 
ported to be promoted differently by GTPyS and 
rab3AL [30]. Whether rab3AL enhances secretion by 
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increasing the recruitment (targeting) of secretory gran- 
ules to the plasma membrane or by facilitating the inter- 
action between the two membranes to allow Ca’+ and 
GTPyS to trigger their fusion. remains to be clarified. 
A putative target protein for rab3A has been identi- 
fied in membranes from rat brain [31] and rab3AL is 
able to induce directly the fusion between the granules 
and the plasma membrane isolated from pancreatic aci- 
nar cells [30]. Therefore the target of rab3AL seems to 
be located on membranes. Accordingly, the action of 
rab3AL was persistent under conditions in which the 
secretory responses to Ca’+ were diminished, probably 
due to the partial loss of cytosolic proteins from the 
permeabilized cells. The extent of cytosolic protein leak- 
age might be underestimated in our determinations, 
since the extraction procedure could have detached 
some loosely membrane-bound proteins into the cy- 
tosolic fractions. 
The fast run-down of the secretory response to Ca” 
stimulation could be due to the loss of crucial cytosolic 
factor(s) or to modifications of the secretory machinery 
(e.g. phosphorylation/dephosphorylation) after perme- 
abilization. The persistence of the GTPyS effect sug- 
gests that the former may be the case. It has been re- 
ported that several proteins are able to restore the secre- 
tory response in reconstitution experiments in other 
cells [32,33]. Such experiments have not yet been per- 
formed in insulin-secreting cells. Although the rab3AL 
was less potent during the initial period of permeabiliza- 
tion in the present study, possibly due to an inefficient 
penetration of the peptide into the cells, the rab3AL was 
not capable of restoring the secretion to the maximal 
levels after run-down. Since most SMGs were still pres- 
ent in the cells. it is unlikely that a rab3-like protein is 
the lost factor causing the run-down of the secretory 
response. 
In conclusion, a synthetic peptide corresponding to 
the rab3 effector domain enhances insulin secretion 
from permeabilized HIT cells. The peptide acts mainly 
by potentiating GTPI/S- and Ca”-elicited release. These 
results suggest that a rab3-like protein and its effector 
may be involved in the regulation of insulin secretion 
and that one of the rab3 proteins participates in the 
control of exocytosis. 
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